Recruiting

Neuromodulation

Sponsor:

Alberta Health Services, Calgary

Code:

NCT04933370

Conditions

Chronic Pain

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Stimulation parameters

Study Details

Brief summary:

The objective of this study is to determine the efficacy of neuromodulation using various stimulation paradigms in the treatment of several disorders including chronic pain.

Conditions

Chronic Pain

Study ID

NCT04933370

Start date

Feb 1, 2022

Status verified date

Aug, 2024

Completion date

Jul 1, 2026

Anticipated

Primary completion date

Jul 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients who are candidates for, and have been consented for, implantation of a neuromodulation device.

Exclusion Criteria:

  • Non-English speaking

Study Design

Enrollment

20 participants

Anticipated

Allocation

Randomized

Intervention Model

Crossover

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

active comparator: Industry standard stimulation

Industry standard stimulation settings

sham comparator: Experimental stimulation

Experimental stimulation settings

Interventions

Stimulation parameters

Different device stimulation parameters

Primary outcome measure

  • Change in baseline pain measures [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Fady Girgis, MD

4039446497fmgirgis@ucalgary.ca

Locations

University of Calgary

Recruiting

Calgary, Alberta, Canada, T2N2T9

Contacts

Fady Girgis, MD

4039446497fmgirgis@ucalgary.ca

More Information

Sponsor

Alberta Health Services, Calgary

Last update posted

Aug 7, 2024

Last verified

Aug, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Alberta Health Services, Calgary on 2024-08-07.